Byotrol Share Price (BYOT)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Byotrol Plc	LSE:BYOT	London	Ordinary Share	GB00B0999995	ORDS 0.25P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.02	1.0%	2.03	1,952,141	11:00:07

Bid Price		Offer Price	High Price	Low Price	Open Price
1.98		2.08	2.03	2.01	2.01

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Chemicals	3.14	-0.24	-0.07		8

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
16:23:34	O	710,000	1.985	GBX

Related Shares
Croda (CRDA), Johnson Matthey (JMAT), Itaconix (ITX), React (REAT)

Byotrol (BYOT) Latest News

Byotrol News

Date	Time	Source	Headline
11/10/2019	17:02	ALNC	Byotrol Releases Annual Results, Shares Suspension Lifted
11/10/2019	15:05	ALNCF	Alliance News Flash Headline
11/10/2019	15:00	UKREG	Byotrol PLC Posting of Accounts, Notice of AGM and Restoration
01/10/2019	15:50	UKREG	Byotrol PLC Holding(s) in Company
01/10/2019	11:39	ALNC	Byotrol Reports Profit On Sales Jump; Shares Suspended On Report Delay
01/10/2019	07:30	UKREG	AIM Suspension - BYOTROL PLC
30/9/2019	12:01	UKREG	Byotrol PLC Publication of accounts and temporary suspension
30/9/2019	12:00	UKREG	Byotrol PLC Unaudited Preliminary Results to 31 March 2019
25/9/2019	07:01	UKREG	Byotrol PLC Notice of Results
03/9/2019	09:08	UKREG	Byotrol PLC Notice of Results

More Byotrol News

Byotrol Takeover Rumours

Byotrol (BYOT) Share Charts

1 Year Byotrol Chart

1 Month Byotrol Chart

Intraday Byotrol Chart

Byotrol (BYOT) Discussions and Chat

Byotrol Forums and Chat

Date	Time	Title	Posts
13/10/2019	23:57	BYOTROL-CAN DELIVER AMAZING RESULTS	3,777
31/7/2018	23:54	Byotrol (BYOT) One to Watch on Wednesday	-
27/2/2016	19:04	Byotrol:::::::::Cleaning Up	45
03/1/2013	09:22	Byotrol - ready to tap a $5.6billion market?	3,489

Add a New Thread

Byotrol (BYOT) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2019-10-17 16:13:24	1.98	710,000	14,058.00	O
2019-10-17 15:23:36	1.99	49,297	981.01	O
2019-10-17 15:20:03	2.00	100,000	2,000.00	O
2019-10-17 13:43:39	1.98	7,887	156.16	O
2019-10-17 13:34:05	2.04	100,000	2,040.00	O

View all Byotrol trades in real-time

Byotrol (BYOT) Top Chat Posts

Date	Subject
17/10/2019 09:20	Byotrol Daily Update: Byotrol Plc is listed in the Chemicals sector of the London Stock Exchange with ticker BYOT. The last closing price for Byotrol was 2.01p. Byotrol Plc has a 4 week average price of 1.75p and a 12 week average price of 1.75p. The 1 year high share price is 3.35p while the 1 year low share price is currently 1.50p. There are currently 402,836,491 shares in issue and the average daily traded volume is 687,773 shares. The market capitalisation of Byotrol Plc is £8,177,580.77. Read Full Thread Reply
06/10/2019 20:03	sikhthetech: 1gw, "The comparison with tly is relevant because of the similarity of the acquisition model," That's exactly my point and what I was saying... you use 'original contingency to state TLY fell short of expectations', yet on here you refer to potential of BYOT's acquisition.. and in your usual devious way, you change your view and, with your smooth posts, make it seem as if your view hasn't changed...your ego get's in the way, eh? But good to see you finally agree with the acquisition model being similar I mentioned the similarity in the acquisition model on the TLY but then you went quiet after I posted this, strange wasn't it, 1gw? sikhthetech - 07 Jun 2019 - 20:42:42 - 9223 of 10490 Totally Health - 2014 onwards - TLY 1gw, There's this company who specialise in disinfectant cleaners... you may have heard of them... Byotrol (BYOT).. They bought Medimark, nearly a yr ago as follows..: 1) Initial consideration of Â£2.3m 2) Â£0.4m Medimark debt 3) Â£1.15m cash 4) Â£1.15m from additional shares @ 4.1p 5) Â£1.8m deferred subject to achieving EBIDTA targets... Total consideration Â£4.5m for a company making ADJUSTED EBITDA of ONLY Â£380k on revenues of just Â£2.7m... using a similar strategy as TLY. "year ended 31 March 2018, Medimark reported adjusted EBITDA of GBP380k on revenues of GBP2.7m." "Consideration of up to GBP4.5m is payable in respect of the Acquisition, which includes GBP0.4m of debt that Byotrol is assuming.. Initial consideration of GBP2.3m is payable on completion, being GBP1.15m in cash and GBP1.15m from 28,048,780 new ordinary shares ("Ordinary Shares") being issued at 4.1p per share. An additional GBP1.8m of consideration is payable subject to achieving EBITDA targets in FYE 31 March 2019 and FYE March 2020. The deferred consideration is also to be paid half in cash and half in new ordinary shares." https://uk.advfn.com/stock-market/london/byotrol-BYOT/share-news/Byotrol-PLC-Acquisition-of-Medimark-Scientific-Lim/78126339 The placing price @ 4.1p, the current share price is around 50% lower @ 2.1p. Your ONE post on the acquisition, on the day of acquisition announced: 1gw - 23 Aug 2018 - 13:10:33 - 3152 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT Nice surprise on my return from the beach! Good to see them get the results out today in the end and I like the fact that the acquisition shares are priced above 4p. Also I agree it sounds like good news that the Target trial is being extended - although I suppose it could mean the results are borderline and they need more time to decide whether it is going to be viable. Didn't you look at the accounts, liabilities, strategy etc, before loading up... Oh you did. Management seem to be doing the right thing, eh... Management seem to be doing the right things... 1gw - 28 Feb 2019 - 15:04:42 - 3455 of 3628 BYOTROL-CAN DELIVER AMAZING RESULTS - BYOT I've bought some more. Takes Byotrol into the top 3 in my portfolio. High risk, but management seem to be doing the right things and sound confident. I think there is potential for the share price to do very well, especially if they can derisk the US by landing some licensing deals now that they've got such a good shop window through the Target trial. Read Full Thread Follow Reply
30/9/2019 20:52	sikhthetech: After over a year on trial... Byot24 remains on trial... Whatever happened to the new retailer they were 'close to securing' 4 months ago...why did that retailer walk away? Todays results: They are NOW SEEKING "US surface care - Byotrol24 remains on trial in 207 Target stores in the US with sales to date satisfactory on minimal marketing spend. Following extensive consumer and market research, which has clearly confirmed the value of the proposition to consumers, the Company is now seeking a partner (financial or corporate) to accelerate growth" May TU: They were CLOSE TO SECURING "In the US, the trial at Target of Byotrol24 surface sanitiser has now been extended across an increased number of stores. Two new long-lasting fragrance versions are now on Target's shelves and the original versions are now being re-propositioned for more-targeted household uses. We are also now close to securing an additional new national retailer trial in the US." https://uk.advfn.com/stock-market/london/byotrol-BYOT/share-news/Byotrol-PLC-Trading-Update/79868900 Read Full Thread Follow Reply
30/9/2019 10:20	mudbath: That's a relevant observation 1gw. On the 23rd August,Byotrol shares closed at 3.65pence. Three months later the share price bottomed at 1.525 on the occasion of the Ruffer disposal. That disposal resulted in a one day churn of 33 million BYOT shares on Dec 20th;so quite a lot of stock for the market to digest over the intervening 9 months. I do hope that the BOD are able to report some meaningful progress allied to profitability when the results are belatedly made available to investors later today. Read Full Thread Follow Reply
06/9/2019 14:49	sikhthetech: "Medimark Scientific will prove to be the engine for growth"... What about rollout to all target stores or new customers... MediaMark Scientific.... Did they pay too much? They bought Medimark, a yr ago as follows..: 1) Initial consideration of £2.3m 2) £0.4m Medimark debt 3) £1.15m cash 4) £1.15m from additional shares @ 4.1p 5) £1.8m deferred subject to achieving EBIDTA targets... Total consideration £4.5m for a company making ADJUSTED EBITDA of ONLY £380k on revenues of just £2.7m... "year ended 31 March 2018, Medimark reported adjusted EBITDA of GBP380k on revenues of GBP2.7m." "Consideration of up to GBP4.5m is payable in respect of the Acquisition, which includes GBP0.4m of debt that Byotrol is assuming.. Initial consideration of GBP2.3m is payable on completion, being GBP1.15m in cash and GBP1.15m from 28,048,780 new ordinary shares ("Ordinary Shares") being issued at 4.1p per share. An additional GBP1.8m of consideration is payable subject to achieving EBITDA targets in FYE 31 March 2019 and FYE March 2020. The deferred consideration is also to be paid half in cash and half in new ordinary shares." https://uk.advfn.com/stock-market/london/byotrol-BYOT/share-news/Byotrol-PLC-Acquisition-of-Medimark-Scientific-Lim/78126339 The placing price @ 4.1p, the current share price is around 50% lower @ 2.1p. Read Full Thread Follow Reply
03/9/2019 13:39	mudbath: With the chart looking as though the share price might be about to go higher,would anyone venture to hazard a guess at the BYOT share price on BREXIT day or October 31st 2019? I could see 3.75p being achievable. Read Full Thread Follow Reply
01/4/2019 09:31	mudbath: Byotrol 24 continues to churn out remarkable content on its US orientated Facebook pages. https://en-gb.facebook.com/Byotrol24/ Generating a stream of proactive input of this quality takes talent. What an opportunity Byotrol,here in the UK,are passing up by not incorporating these eye catching promotions into their own blogs,twitter feed, etc. At least Medimark are "bigging up" their achievements on an almost daily basis. The BYOT share price looks poised to move significantly higher. Read Full Thread Follow Reply
02/3/2019 10:09	mudbath: A significant 928,089 delayed buy trade underlines my current view that the BYOT share price could well swiftly move above 3 pence and beyond. Byotrol's engagement of Alex Espalin (Ex product launch man at Kimberly-Clark Corporation)looks to be inspired,having regard to the speed with which he has overseen the EPA approval being gained and the introduction of Byotrol 24 across a growing number of TARGET stores,not to mention his stimulating the interest of other retailers in the product. This compares extremely favourably with Tristel's similar US endevours where they have spent 5 YEARS gaining EPA regulatory approval,only to issue the following statement alongside last weeks Interim Results :- "Furthermore, we have decided that our most prudent approach is to postpone commercialising the EPA approvals already obtained for our Duo and Jet products until we have greater visibility of the way ahead for the FDA project."..... "Conferring with consultants, peer companies and industry experts, we are led to believe that we should not be dismayed by the time it has taken to reach the point we are at today; nor by the cumulative cost, which amounted at 31 December 2018 to GBP1.3m." Byotrol/Medimark Scientific look poised to make inroads into Tristel's markets. Happy days ! Read Full Thread Follow Reply
25/2/2019 10:05	mudbath: Investing is all about timing and if anyone missed the opportunity to mop up those Ruffer shares @ just 1.50 pence then fear not,for BYOT remain a total steal at today's 2.40 pence to buy.Remember that Medimark Scientific was purchased with Byotrol shares valued at 4.10 pence and with cash,also raised @ 4.0 pence. Listening to the vibes it looks as though BYOT are on something of a roll at the moment,with the market due to be appraised of progress in an upcoming trading update. It seems logical,to me,that the BYOT share price will soon resume its upward trajectory;maybe even in a vigorous fashion. BUY. NOW !! Read Full Thread Follow Reply
02/1/2019 13:02	mudbath: It looks as though the BYOT share price is about to move back towards fair value at a rate of knots, now that Ruffer have curtailed the recent dumping of the majority of their holding at that ludicrous 1.55 pence level. Nevertheless, Ruffer still hold 21 million shares,which could yet lead to future weakness if they intend to fully exit their position. Read Full Thread Follow Reply
09/5/2018 08:45	mudbath: After all,the conclusion of Byotrol's interim report read, "The recent fund raising of £4.6m, net of expenses, has given us the financial resources to grow and has secured some first-class new investors on our shareholder register. Our challenge now is to execute the commercial plan and deliver to the financial targets. The team is confident it will do so and looks forward to substantial progress in the second half of the financial year. We continue to look to our long-term future with confidence and excitement." The perverse market reaction to this most positive of statements was to take the BYOT share price down to its lowest ever level. It looks as though the market is now reconsidering the potential for Byotrol to shed its status as a "jam tomorrow company";hence the initial start of an upward movement in the SP,which might just evolve into an upward re rating of some significance. Read Full Thread Follow Reply

Byotrol share price data is direct from the London Stock Exchange

Your Recent History

LSE

BYOT

Byotrol

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20191018 00:11:44